Oxford Covid-19 vaccine's first human trial shows promise, more phases underway

The vaccine called AZD1222 was developed by Oxford University’s Jenner Institute and licensed to the multinational pharmaceutical company, AstraZeneca.

from Hindustan Times - world https://bit.ly/2WAaV7N
https://ift.tt/2zbki14